Table 2 The distribution of BCCs and WSIs into the different classes.
All included | Training and validation set | Hold-out test set | ||||
|---|---|---|---|---|---|---|
Number of cases | WSIs | Number of cases | WSIs | Number of cases | WSIs | |
Total | 479 | 1832 | 369 | 1435 | 110 | 397 |
2 classes (Task 1) | ||||||
No tumor | 4 | 745* | 2 | 594 | 2 | 151 |
Tumor | 475 | 1087 | 367 | 841 | 108 | 246 |
3 classes (Task 2) | ||||||
No tumor | 4 | 745 | 2 | 594 | 2 | 151 |
Low risk | 219 | 506 | 178 | 403 | 41 | 103 |
High risk | 256 | 581 | 189 | 438 | 67 | 143 |
5 classes (Task 3) | ||||||
No tumor | 4 | 745 | 2 | 594 | 2 | 151 |
Low aggressive superficial | 81 | 230 | 63 | 177 | 18 | 53 |
Low aggressive nodular | 138 | 276 | 115 | 226 | 23 | 50 |
Medium aggressive | 138 | 294 | 98 | 215 | 40 | 79 |
High aggressive | 118 | 287 | 91 | 223 | 27 | 64 |